Lv55
930 积分 2023-04-12 加入
A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation
3个月前
已完结
A Multi‐center, Randomized, Double‐Blinded, Parallel, Active and Placebo‐Controlled Phase 3 Clinical Study of the glucokinase activator PB‐201 in Treatment‐naive Patients with Type 2 Diabetes Mellitus: A Study Protocol
4个月前
已完结
A model‐informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong‐acting dipeptidyl peptidase‐4 inhibitor
4个月前
已完结
A Model-Informed Approach to Accelerate the Clinical Development of Janagliflozin, an Innovative SGLT2 Inhibitor
4个月前
已完结
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug–Drug Interactions
4个月前
已完结
The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway
4个月前
已完结
Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes
5个月前
已完结
Comparison of Child-Pugh (CP) criteria and NCI organ dysfunction working group (NCI-ODWG) criteria for hepatic dysfunction (HD): Implications for chemotherapy dosing
6个月前
已关闭
皖公网安备34019202002308
